| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |